Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures

Bioorg Med Chem Lett. 2019 Apr 15;29(8):959-964. doi: 10.1016/j.bmcl.2019.02.024. Epub 2019 Feb 21.

Abstract

We have synthesized 3 analogs of the dopamine D2 receptor (D2 DR) antagonist spiperone that can be conjugated to streptavidin-coated quantum dots via a pegylated biotin derivative. Using fluorescent imaging we demonstrate that substitution on the spiro position is tolerated, whilst the length and rigidity of a spacer arm attached to spiperone is important in controlling specific labeling as well as minimizing nonspecific labeling to cells and the surface of cell culture dishes. The ligand with the most rigid linker IDT772 (4) had the best binding profile and had high specific binding to D2 DR expressing HEK-293T cells with low nonspecific binding to plates and HEK-293T cells that lacked the D2 DR.

Keywords: Antagonist; D2 receptor; Fluorescent imaging; Quantum dot; Receptor tracking; Spiperone.

MeSH terms

  • Biotin / chemistry*
  • Dopamine D2 Receptor Antagonists / chemistry
  • HEK293 Cells
  • Humans
  • Ligands
  • Microscopy, Fluorescence
  • Quantum Dots / chemistry*
  • Receptors, Dopamine D2 / chemistry
  • Receptors, Dopamine D2 / genetics
  • Receptors, Dopamine D2 / metabolism*
  • Spiperone / chemistry*
  • Streptavidin / chemistry

Substances

  • Dopamine D2 Receptor Antagonists
  • Ligands
  • Receptors, Dopamine D2
  • Spiperone
  • Biotin
  • Streptavidin